StreetAlpha.app
Home › Stocks › SHC

Sotera Health Co (SHC)

Healthcare
$15.91
▼ −1.85%
LAST CLOSE · NOV 20

Sotera Health provides outsourced sterilization services and Co-60 radiation sources for medical device, drug and food companies. It last closed at $15.91 on Nov 20, down 1.85% on the day. The next earnings report for SHC is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, SHC reported EPS of $0.20 on revenue of $324.9M, with revenue up 4.4% from a year ago. Over its last 8 reports the stock moved an average of 6.4% the session after earnings. Over the last 12 months SHC insiders bought $0 of stock on the open market and sold $1.8B, according to SEC Form 4 filings.

AI Auto Pilots
Is SHC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SHC.

Key Stats

Last 12 months
Results
Revenue
$1.2B
+6.9% vs a year ago
Net income
$173.5M
+213.0% vs a year ago
EPS (diluted)
$0.60
+200.0% vs a year ago
Free cash flow
$135.4M
11.0% margin
Valuation
Market cap
$4.5B
285.6M shares
P/E
26.5
Price over 12 month EPS
Price to sales
3.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$412.4M
At Sep 30
Debt
$2.1B
At Sep 30
Shareholder equity
$733.2M
Shares outstanding
285.6M
At Oct 27
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $931.5M$931.5MFY2021FY2022: $1.0B$1.0BFY2022FY2023: $1.0B$1.0BFY2023FY2024: $1.1B$1.1BFY2024FY2025: $1.2B$1.2BFY2025

From SHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.20
Quarter ended Sep 2026
Year ago EPS
$0.17
+17.6% on a GAAP basis
Revenue
$324.9M
+4.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.05Dec '24Mar 2025: -$0.05Mar '25Jun 2025: $0.03Jun '25Sep 2025: $0.17Sep '25Dec 2025: $0.12Dec '25Mar 2026: $0.09Mar '26Jun 2026: $0.19Jun '26Sep 2026: $0.20Sep '26Latest $0.20
Revenue by quarter
Dec 2024: $290.2MDec '24Mar 2025: $254.5MMar '25Jun 2025: $294.3MJun '25Sep 2025: $311.3MSep '25Dec 2025: $303.4MDec '25Mar 2026: $280.0MMar '26Jun 2026: $321.4MJun '26Sep 2026: $324.9MSep '26Latest $324.9M
How SHC moved after its last 8 reports
Average move the session after a report ±6.4%
Nov 3, 2026Time not announced−9.6%
Aug 6, 2026Time not announced+5.2%
May 5, 2026Time not announced−0.4%
Feb 24, 2026Time not announced−4.4%
Jan 12, 2026Time not announced−1.1%
Nov 4, 2025Time not announced−1.1%
Aug 8, 2025Time not announced+24.5%
May 1, 2025Time not announced+5.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SHCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SHC
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SHC

Technical Analysis

SHC · as of the Nov 20 close · updated each morning
Turning down, nearing oversold

The stock is 6% below its 20 day and 11% below its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the Pivot S1 at $15.70, and the nearest resistance the Pivot at $16.02.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 3.4%/day
Key levels
$19.8552 week high+24.8%
$18.06100 day average+13.5%
$17.7350 day average+11.4%
$16.8620 day average+6.0%
$16.84200 day average+5.8%
$16.23Pivot R1+2.0%
$16.10Swing high (May 27)+1.2%
$16.02Pivot+0.7%
$15.91Last close
$15.70Pivot S1−1.3%
$15.64Swing low (Nov 6)−1.7%
$13.0952 week low−17.7%
Indicators
RSI (14)36.23Weak, oversold below 30Neutral
MACD-0.51Below its signal lineBearish
Stochastic18.9Near the bottom of its rangeOversold
ADX (14)23.3Weak trend
Williams %R-83.8Oversold below −80, overbought above −20Oversold
CCI (20)-65.7Oversold below −100, overbought above 100Neutral
Rate of change−0.6%Change over 10 sessionsBearish
ATR (14)$0.54Typical daily range, 3.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SHC

What happened before

See how SHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SHCHow many large options trades hit SHC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

SHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲228 buying vs 105 selling
  • ▼Held by funds -4.3 pts
  • ▲Funds holding +30
  • ▼Superinvestors: 1 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding350320+9.4%
In funds' top 101415−6.7%
Held by funds99.2%103.5%−4.3 pts
New / increased69 / 15954 / 164+4.6%
Reduced / sold out72 / 3367 / 35+2.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SHC Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$1.8B12 sales · 9 insiders
2025-12 sold $435.6M2026-03 sold $610.8M2026-05 sold $772.7M2026-08 sold $24.0MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 17Michael B. Petras Jr.Executive ChairmanSale1,144,515$18.50$21.2M
Aug 7Michael P RutzPresident of SterigenicsSale150,000$18.84$2.8M
May 13Gtcr Investment Xi LLCDirectorSale12,735,301$15.17$193.2M
May 13Warburg Pincus & Co.DirectorSale19,102,952$15.17$289.8M
May 13Warburg Pincus & Co.DirectorSale19,102,952$15.17$289.8M
Mar 6Gtcr Co-invest Xi LPDirectorSale10,000,000$15.27$152.7M
Every insider buy and sale for SHC over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SHC insider trades →

From SEC Form 4 filings by SHC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SHC is in one of them and how their past SHC trades turned out.

SHC in the AI portfolios
Loading…

SHC News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SHC in an article yet. Here's the latest on the wider market.

SHC in the news

About Sotera Health

Sotera Health provides outsourced sterilization services that help ensure medical devices, pharmaceuticals, and food products are safe for use. Its Sterigenics business sterilizes products in their final packaging using gamma, ethylene oxide, and electron beam methods, and also offers microbial reduction for food and irradiation services for industrial materials. Its Nordion business supplies Co-60, a radioactive isotope used in gamma sterilization and cancer treatment, along with gamma irradiation systems. Customers include medical device makers, drug companies, food producers, and other manufacturers, and the company is based in Broadview Heights, Ohio.

Headquarters
Broadview Heights, OH